Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Articles by Özge Özkaya
Recent Posts
- Phase 3 trial is tracking use of acoramidis to block ATTR onset
- I wish my country could benefit from gains in amyloidosis treatment
- Long-term Amvuttra treatment safe, pooled trial analysis shows
- Gene therapy nex-z lowers FAP protein levels for 3 years
- YOLT-201 therapy for FAP, other forms of ATTR gets funding boost
